What is 10x Genomics, Inc.'s deferred revenue?

10x Genomics, Inc. (TXG) reported deferred revenue of $77K in Q1 2026.

How has 10x Genomics, Inc.'s deferred revenue changed year-over-year?

10x Genomics, Inc.'s deferred revenue decreased by 77.8% year-over-year, from $347K to $77K.

What is the long-term trend for 10x Genomics, Inc.'s deferred revenue?

Over 4 years (2021 to 2025), 10x Genomics, Inc.'s deferred revenue has grown at a -16.5% compound annual growth rate (CAGR), from $1.54M to $746K.

10x Genomics, Inc. TXG Deferred Revenue

Deferred Revenue at other companies

UnitedHealth GroupUNH

$20M+300%

AirbnbABNB

$988M-10.6%

FAN

Diamondback EnergyFANG

$70M-16.7%

Cadence Design SystemsCDNS

$20.42M+242%

MPLXMPLX

-$1M+91.7%

CortevaCTVA

-$2.28B0.0%

Other financials

Income statement

See full

Revenue$150.8M-2.6%

Gross profit$106.2M+0.7%

Operating income-$17.0M+56.7%

Net income-$13.5M+60.8%

EPS (diluted)-$0.10+64.3%

Balance sheet

See full

Cash & equivalents$490.3M+30.0%

Total debt$81.4M+1.6%

Total equity$814.3M+15.2%

Total assets$1.0B+12.4%

Cash flow

See full

Operating cash flow$26.1M-24.0%

CapEx$1.6M-15.6%

Free cash flow$24.5M-24.4%

Valuation

See full

Market cap$4.41B+154%

Profitability

See full

Gross margin69.6%+1.2pp

Operating margin-6.1%-2.7pp

Net margin-3.5%-1.6pp

FCF margin19.1%—

Returns & leverage

See full

Return on equity-3%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredRevenue.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 10x Genomics, Inc.'s deferred revenue?: 10x Genomics, Inc. (TXG) reported deferred revenue of $77K in Q1 2026.
How has 10x Genomics, Inc.'s deferred revenue changed year-over-year?: 10x Genomics, Inc.'s deferred revenue decreased by 77.8% year-over-year, from $347K to $77K.
What is the long-term trend for 10x Genomics, Inc.'s deferred revenue?: Over 4 years (2021 to 2025), 10x Genomics, Inc.'s deferred revenue has grown at a -16.5% compound annual growth rate (CAGR), from $1.54M to $746K.